BALAXI — Balaxi Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹6.35bn
- IN₹6.27bn
- IN₹3.36bn
- 39
- 17
- 66
- 32
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,439 | 88.7 | 443 | 545 | 569 |
Depreciation | |||||
Non-Cash Items | 1.7 | 0.094 | -8.82 | 6.78 | 62.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,952 | -230 | -437 | -216 | -589 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1,507 | -141 | 0.032 | 341 | 60.8 |
Capital Expenditures | -5.4 | -1.83 | -12.8 | -53.2 | -131 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | -47 | -231 | 24.9 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.4 | -1.83 | -59.7 | -284 | -106 |
Financing Cash Flow Items | — | — | -0.131 | -1.42 | -3.54 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 181 | 36.5 | -1.63 | 255 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,513 | 38.8 | -23.2 | 55.3 | 210 |